ArticleFrontiers in oncology2022

CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway.

Chaozheng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.